Published in Invest Ophthalmol Vis Sci on December 13, 2013
Looking the cow in the eye: deletion in the NID1 gene is associated with recessive inherited cataract in Romagnola cattle. PLoS One (2014) 1.11
Pharmacotherapy of glaucoma. J Ocul Pharmacol Ther (2015) 0.84
Effects of Lutein and Zeaxanthin on LPS-Induced Secretion of IL-8 by Uveal Melanocytes and Relevant Signal Pathways. J Ophthalmol (2015) 0.79
Absorption, metabolism, and functions of β-cryptoxanthin. Nutr Rev (2016) 0.78
Progression Rate From Intermediate to Advanced Age-Related Macular Degeneration Is Correlated With the Number of Risk Alleles at the CFH Locus. Invest Ophthalmol Vis Sci (2016) 0.77
Accumulation of cholesterol and increased demand for zinc in serum-deprived RPE cells. Mol Vis (2016) 0.77
Management of Ocular Diseases Using Lutein and Zeaxanthin: What Have We Learned from Experimental Animal Studies? J Ophthalmol (2015) 0.76
Effects of Lutein on Hyperosmoticity-Induced Upregulation of IL-6 in Cultured Corneal Epithelial Cells and Its Relevant Signal Pathways. J Ophthalmol (2016) 0.75
Flavonoid intake and the risk of age-related cataract in China's Heilongjiang Province. Food Nutr Res (2015) 0.75
Prevalence, adverse health, and risk factors in association with sensory impairments: data from a prospective cohort study of older Japanese. Environ Health Prev Med (2016) 0.75
Quantitative metabolomics of photoreceptor degeneration and the effects of stem cell-derived retinal pigment epithelium transplantation. Philos Trans A Math Phys Eng Sci (2016) 0.75
Serum starvation of ARPE-19 changes the cellular distribution of cholesterol and Fibulin3 in patterns reminiscent of age-related macular degeneration. Exp Cell Res (2017) 0.75
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol (2001) 21.37
Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol (2004) 18.86
Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol (2004) 13.78
Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA (1994) 5.43
The Lens Opacities Case-Control Study. Risk factors for cataract. Arch Ophthalmol (1991) 4.93
Prevalence of cataract and pseudophakia/aphakia among adults in the United States. Arch Ophthalmol (2004) 3.78
Oral zinc in macular degeneration. Arch Ophthalmol (1988) 3.58
Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA (2013) 3.53
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol (2001) 3.49
The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22. Arch Ophthalmol (2007) 3.02
Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake. Arch Ophthalmol (2003) 2.50
Dietary fat and risk for advanced age-related macular degeneration. Arch Ophthalmol (2001) 2.27
Antioxidant status and neovascular age-related macular degeneration. Eye Disease Case-Control Study Group. Arch Ophthalmol (1993) 2.24
Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration. Arch Ophthalmol (2006) 2.21
The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23. Arch Ophthalmol (2008) 1.93
Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology (2007) 1.90
Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study. Arch Intern Med (2009) 1.83
Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study. Am J Epidemiol (1998) 1.65
Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age-related maculopathy. Arch Ophthalmol (2004) 1.63
Age-related cataract in a randomized trial of vitamins E and C in men. Arch Ophthalmol (2010) 1.60
Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the third national health and nutrition examination survey. Am J Epidemiol (2001) 1.59
Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-related Eye Disease Study (CAREDS): ancillary study of the Women's Health Initiative. Arch Ophthalmol (2006) 1.55
Vitamin E supplementation and cataract: randomized controlled trial. Ophthalmology (2004) 1.48
{omega}-3 Long-chain polyunsaturated fatty acid intake and 12-y incidence of neovascular age-related macular degeneration and central geographic atrophy: AREDS report 30, a prospective cohort study from the Age-Related Eye Disease Study. Am J Clin Nutr (2009) 1.44
Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35. Ophthalmology (2013) 1.38
Prospective cohort study of antioxidant vitamin supplement use and the risk of age-related maculopathy. Am J Epidemiol (1999) 1.35
The Linxian cataract studies. Two nutrition intervention trials. Arch Ophthalmol (1993) 1.32
Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4. JAMA Ophthalmol (2013) 1.31
Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration. Am J Clin Nutr (2008) 1.29
A randomized, double-masked, placebo-controlled clinical trial of multivitamin supplementation for age-related lens opacities. Clinical trial of nutritional supplements and age-related cataract report no. 3. Ophthalmology (2008) 1.24
Clinical detection of precataractous lens protein changes using dynamic light scattering. Arch Ophthalmol (2008) 1.23
Dietary fatty acids and the 5-year incidence of age-related maculopathy. Arch Ophthalmol (2006) 1.22
The use of vitamin supplements and the risk of cataract among US male physicians. Am J Public Health (1994) 1.19
Genetic insights into age-related macular degeneration: controversies addressing risk, causality, and therapeutics. Mol Aspects Med (2012) 1.16
Antioxidant vitamins and nuclear opacities: the longitudinal study of cataract. Ophthalmology (1998) 1.15
Long-term nutrient intake and early age-related nuclear lens opacities. Arch Ophthalmol (2001) 1.15
The impact of fish and shellfish consumption on age-related macular degeneration. Ophthalmology (2010) 1.11
A randomized trial of beta carotene and age-related cataract in US physicians. Arch Ophthalmol (2003) 1.09
Neovascular age-related macular degeneration and its relationship to antioxidant intake. Acta Ophthalmol Scand (2002) 1.08
Genetic studies of age-related macular degeneration: lessons, challenges, and opportunities for disease management. Ophthalmology (2012) 1.07
Vitamin supplement use and incident cataracts in a population-based study. Arch Ophthalmol (2000) 1.06
Omega-3 long-chain polyunsaturated fatty acid intake inversely associated with 12-year progression to advanced age-related macular degeneration. Arch Ophthalmol (2009) 1.05
The Antioxidants in Prevention of Cataracts Study: effects of antioxidant supplements on cataract progression in South India. Br J Ophthalmol (2006) 1.02
Long-term supplementation with alpha-tocopherol and beta-carotene and age-related cataract. Acta Ophthalmol Scand (1997) 1.01
Use of vitamin supplements and cataract: the Blue Mountains Eye Study. Am J Ophthalmol (2001) 0.97
Age-related cataract in a randomized trial of beta-carotene in women. Ophthalmic Epidemiol (2004) 0.96
Dietary antioxidant intake and incidence of early age-related maculopathy: the Blue Mountains Eye Study. Ophthalmology (2002) 0.91
Vitamin E and age-related cataract in a randomized trial of women. Ophthalmology (2007) 0.90
Impairments in Dark Adaptation Are Associated with Age-Related Macular Degeneration Severity and Reticular Pseudodrusen. Ophthalmology (2015) 0.90
Drusen Volume and Retinal Pigment Epithelium Abnormal Thinning Volume Predict 2-Year Progression of Age-Related Macular Degeneration. Ophthalmology (2015) 0.87
Relationship of central choroidal thickness with age-related macular degeneration status. Am J Ophthalmol (2014) 0.85
A Crossover Design for Comparative Efficacy: A 36-Week Randomized Trial of Bevacizumab and Ranibizumab for Diabetic Macular Edema. Ophthalmology (2016) 0.79
Imaging Protocols in Clinical Studies in Advanced Age-Related Macular Degeneration: Recommendations from Classification of Atrophy Consensus Meetings. Ophthalmology (2017) 0.78
Decreased Visual Function Scores on a Low Luminance Questionnaire Is Associated with Impaired Dark Adaptation. Ophthalmology (2017) 0.75
Optical Coherence Tomography Predictors of Risk for Progression to Non-Neovascular Atrophic Age-Related Macular Degeneration. Ophthalmology (2017) 0.75
CORRELATION OF STRUCTURAL AND FUNCTIONAL OUTCOME MEASURES IN A PHASE ONE TRIAL OF CILIARY NEUROTROPHIC FACTOR IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA. Retina (2017) 0.75
ABNORMAL RETINAL REFLECTIVITY TO SHORT-WAVELENGTH LIGHT IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA. Retina (2017) 0.75
CHARACTERISTICS OF PIGMENTED LESIONS IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA. Retina (2017) 0.75